He'Nan Kangtai Pharmaceutical Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

He'nan Kangtai Pharmaceutical Co.,Ltd.

31 YRS

Henan, China

CNY 52.2 Million

99900 m²

100-500 people

Main Products: Norfloxacin

Henan, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturer

Total Employees

100-500 People

Plant Size

150 Acres

Production Experience

31+ Years

Registered Capital

CNY 52.2 Million

MAIN
PRODUCTS

1/3

Norfloxacin

CAS: 70458-96-7

Packing: 25 KG/Fibre Drum

Lead Time: In Stock

Inquiry

ABOUT US

He'nan Kangtai Pharmaceutical Co.,Ltd.

He'nan Kangtai Pharmaceutical Co., Ltd. founded in 1993, is located in the picturesque ancient city of Xingyang in He'nan Province. Close to Longhai Railway and Kai-luo highway, the company enjoys convenient transportation. We have registered capital of 52.23 million RMB yuan and total occupied floor area of 100,000 sq. meters as well as 365 employees. Over the past decades, we have been committed to the R&D of hi-tech products, achieving considerable economic and social benefits. And we have ever been honored as He'nan Provincial Hi-tech Enterprise, Example Enterprise in Technological Innovation in He'nan Province, to name just a few. And in the year 2000, we were authorized the self-support imp. & exp. power. Our leading product is norfloxacin(fluperacid) API, which, with an annual output of 1,000mts/a., was listed as He'nan Provincial Key Project in Industrial Application of New and High Technologies. Products have been exported and enjoying good reputation overseas. At present, the manufacturing shops of norfloxacin have been certified by GMP. In 2005, with an investment of over 8 million RMB yuan, we successfully developed State Class I New Drug--gatifloxacin methanesulfonate, which has reached the world's top level and supplied a gap in the development of quinolones in China. The estimated domestic market share occupied can reach 20% or so. Overall Development Thought: To be based on the research and development of quinolones antibacterial drugs and intermediates; boost the production of preparations; strive to develop 1 kind of state Class I and Class II new drug respectively in 3-5 years' time, and to become one of the major domestic production bases of quinolones.